SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Olema to Present Palazestrant and OP-3136 Combination Data at Breast Cancer Symposium

Olema Pharmaceuticals says it will present combination data from its palazestrant and OP-3136 programs at the 2026 San Antonio Breast Cancer Symposium.

OLMA

Related stories